Related references
Note: Only part of the references are listed.Oncogenic and Wild-type Ras Play Divergent Roles in the Regulation of Mitogen-Activated Protein Kinase Signaling
Amy Young et al.
CANCER DISCOVERY (2013)
Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance
Edita Aksamitiene et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma
Karen S. Yee et al.
CANCER RESEARCH (2012)
Integrating developmental signals: a Hippo in the (path) way
A. Mauviel et al.
ONCOGENE (2012)
Sos-mediated cross-activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis
Hao-Hsuan Jeng et al.
NATURE COMMUNICATIONS (2012)
Mutant K-Ras Activation of the Proapoptotic MST2 Pathway Is Antagonized by Wild-Type K-Ras
David Matallanas et al.
MOLECULAR CELL (2011)
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
William H. Chappell et al.
ONCOTARGET (2011)
Proapoptotic Kinase MST2 Coordinates Signaling Crosstalk between RASSF1A, Raf-1, and Akt
David Romano et al.
CANCER RESEARCH (2010)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
A Hippo in the ointment - MST signalling beyond the fly
David Matallanas et al.
CELL CYCLE (2008)
Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II
Benjamin Stieglitz et al.
EMBO JOURNAL (2008)
Wild-type NRas and KRas perform distinct functions during transformation
Poppy P. Fotiadou et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
RASSRA elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the P73 tumor suppressor protein
David Matallanas et al.
MOLECULAR CELL (2007)
The RASSF1A tumor suppressor
Howard Donninger et al.
JOURNAL OF CELL SCIENCE (2007)
RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network
Cai Guo et al.
CURRENT BIOLOGY (2007)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
Growth factor-dependent AKT activation and cell migration requires the function of c-K(B)-Ras versus other cellular Ras isoforms
Jinhui Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The RASSF1A tumor suppressor activates Bax via MOAP-1
MD Vos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to bax conformational change and cell death
S Baksh et al.
MOLECULAR CELL (2005)
The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage
S Strano et al.
MOLECULAR CELL (2005)
Role of the ras-association domain family 1 tumor suppressor gene in human cancers
A Agathanggelou et al.
CANCER RESEARCH (2005)
Activation of H-Ras in the endoplasmic reticulum by the RasGRF family guanine nucleotide exchange factors
I Arozarena et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Rote of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1
E O'Neill et al.
SCIENCE (2004)
Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras
M Praskova et al.
BIOCHEMICAL JOURNAL (2004)
Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate
P Rodriguez-Viciana et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The dark side of Ras: regulation of apoptosis
AD Cox et al.
ONCOGENE (2003)
ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer
G Garcia-Rostan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Differences on the inhibitory Specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane Microlocalization
D Matallanas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1
S Ortiz-Vega et al.
ONCOGENE (2002)
Identification of a novel Ras-regulated proapoptotic pathway
A Khokhlatchev et al.
CURRENT BIOLOGY (2002)
Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis
MD Vos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The Rho family GTPase Cdc42 regulates the activation of Ras/MAP kinase by the exchange factor Ras-GRF
I Arozarena et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
